Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Epoetina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 461

  • Page / 19
Export

Selection :

  • and

Place of Epoetin and Novo7 in Belgian anaesthesia & ICU practice: a clinical perspectiveDE DECKER, K.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, pp 129-131, issn 0001-5164, 3 p.Conference Paper

Differentiating factors between erythropoiesis-stimulating agents: A guide to selection for anaemia of chronic kidney diseaseDEICHER, Robert; HÖRL, Walter H.Drugs (Basel). 2004, Vol 64, Num 5, pp 499-509, issn 0012-6667, 11 p.Article

Optimising anaemia management with epoetin betaREED, Nicholas; MORERE, Jean-Francois.Oncology. 2004, Vol 67, pp 12-16, issn 0030-2414, 5 p., SUP1Conference Paper

Role of epoetin alfa in maintaining ribavirin doseAFDHAL, Nezam H.Gastroenterology clinics of North America. 2004, Vol 33, Num 1S, pp xviii-xix, issn 0889-8553, 12 p., SUPArticle

A study of the response of elderly patients with end-stage Renal disease to epoetin alfa or betaNICHOLAS, Johann C. B.Drugs & aging. 2004, Vol 21, Num 3, pp 187-201, issn 1170-229X, 15 p.Article

Clinical and economic impact of epoetins in cancer careMARCHETTI, Monia; BAROSI, Giovanni.PharmacoEconomics (Auckland). 2004, Vol 22, Num 16, pp 1029-1045, issn 1170-7690, 17 p.Article

Époétines : Surmortalité dose-dépendante = Epoetins and dose-response overmortalityLa Revue Prescrire. 2007, Vol 27, Num 282, pp 268-268, issn 0247-7750, 1 p.Article

Pain at the injection site of subcutaneously administered erythropoietin : phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin betaVEYS, n; DHONDT, N. V. A; LAMEIRE, N et al.Clinical nephrology. 1998, Vol 49, Num 1, pp 41-44, issn 0301-0430Article

Evaluating erythropoietic agents for the treatment of anaemia in the oncology settingGASCON, Pere.European journal of cancer (1990). 2005, Vol 41, Num 17, pp 2601-2612, issn 0959-8049, 12 p.Article

Gentechnische Herstellung von Arzneimitteln und ihre Anwendung am Beispiel des Erythropoetins = Genetically engineered drugs and their application of recombinant erythropoietinDONATZ, V; ZAHNER, J.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2001, Vol 36, Num 7, pp 440-444, issn 0939-2661Article

Is there a possible survival benefit to increasing hemoglobin levels with epoetin alfa during chemotherapy?AAPRO, M; BAJETTA, E; FREUND, M et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 20-28, issn 1359-6349, 9 p.Conference Paper

Epoetin alfa has potential efficacy in central nervous system disordersCERAMI, A; BRINES, M; CERAMI, C et al.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 29-35, issn 1359-6349, 7 p.Conference Paper

Epoetin-associated pure red cell aplasia : past, present, and future considerationsMCKOY, June M; STONECASH, Robin E; COURNOYER, Denis et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 8, pp 1754-1762, issn 0041-1132, 9 p.Article

Strategies for optimizing hemoglobin response in cancer patients: focus on new epoetin alfa dosing regimensSABBATINI, P.European journal of cancer. Supplement (1990). 2004, Vol 2, Num 2, pp 36-40, issn 1359-6349, 5 p.Conference Paper

Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology PracticeMINUTOLO, Roberto; CONTE, Giuseppe; SASSO, Ferdinando C et al.Blood purification. 2013, Vol 36, Num 2, pp 69-77, issn 0253-5068, 9 p.Article

Epoetin-induced autoimmune pure red cell aplasiaCASADEVALL, Nicole; ECKARDT, Kai-Uwe; ROSSERT, Jérome et al.Journal of the American Society of Nephrology. 2005, Vol 16, pp S67-S69, issn 1046-6673, SUP1Conference Paper

Dose tailoring strategies in haemodialysis patients : a discussion of case historiesKLEOPHAS, Werner.Nephrology, dialysis, transplantation (Print). 2005, Vol 20, pp vi31-vi36, issn 0931-0509, SUP6Conference Paper

Fréquence de l'anémie et indications du traitement par époétine chez l'insuffisant rénal chronique au stade prédialytique = Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stageJUNGERS, Pierre-Yves; NGUYEN-KHOA, Thao; JOLY, Dominique et al.La Presse médicale (1983). 2003, Vol 32, Num 5, pp 212-216, issn 0755-4982, 5 p.Article

Anaemia management prior to dialysis: cardiovascular and cost-benefit observationsCOLLINS, Allan J.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, pp ii2-ii6, issn 0931-0509, SUP2Conference Paper

Optimizing Clinical Benefits: Shaping the Future of Renal Anaemia with EpoetinNephrology, dialysis, transplantation (Print). 2002, Vol 17, issn 0931-0509, 79 p., SUP1Conference Proceedings

A rationale for an individualized haemoglobin targetMUIRHEAD, Norman.Nephrology, dialysis, transplantation (Print). 2002, Vol 17, pp 2-7, issn 0931-0509, SUP6Conference Paper

Recommandations pour la pratique clinique : Standards, Options et Recommandations 2003 pour l'utilisation de l'érythropoïétine recombinante (époetine alfa et bêta, darbepoetine alfa, EPO) dans la prise en charge de l'anémie en cancérologie, mise à jour (rapport abrégé) = Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - update 2003SPAFTH, Dominique; CASAUEVALL, Nicole; DAOUPHARS, Mikaël et al.Bulletin du cancer. 2004, Vol 91, Num 2, pp 179-188, issn 0007-4551, 10 p.Article

Sport et erythropoietine: Rappels, effets et prévention = EPO misuse and sport: Preventive actionDINE, G; VAN LIERDE, F; REHN, Y et al.L' Eurobiologiste (Paris). 2000, Vol 34, Num 245, pp 39-46, issn 0999-5749Article

Dose Efficiency of Erythropoiesis-Stimulating Agents for the Treatment of Patients With Chemotherapy-Induced Anemia: A Systematic ReviewFORBES, Carol A; WORTHY, Gillian; HARKER, Julie et al.Clinical therapeutics. 2014, Vol 36, Num 4, pp 594-610, issn 0149-2918, 17 p.Article

Update on the pharmacotherapy for myelodysplastic syndromesDUONG, Vu H; KOMROKJI, Rami S; LIST, Alan F et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 13, pp 1811-1825, issn 1465-6566, 15 p.Article

  • Page / 19